Targeting IL-6 trans-signalling: past, present and future prospects

S Rose-John, BJ Jenkins, C Garbers, JM Moll… - Nature Reviews …, 2023 - nature.com
Abstract Interleukin-6 (IL-6) is a key immunomodulatory cytokine that affects the
pathogenesis of diverse diseases, including autoimmune diseases, chronic inflammatory …

[PDF][PDF] COVID-19 and the human innate immune system

JL Schultze, AC Aschenbrenner - Cell, 2021 - cell.com
The introduction of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) into the
human population represents a tremendous medical and economic crisis. Innate immunity …

TLR3 and TLR7 RNA sensor activation during SARS-CoV-2 infection

D Bortolotti, V Gentili, S Rizzo, G Schiuma, S Beltrami… - Microorganisms, 2021 - mdpi.com
(1) Background: Acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiological
agent for the coronavirus disease (COVID-19) that has led to a pandemic that began in …

Oral microbiome dysbiosis is associated with symptoms severity and local immune/inflammatory response in COVID-19 patients: a cross-sectional study

I Soffritti, M D'Accolti, C Fabbri, A Passaro… - Frontiers in …, 2021 - frontiersin.org
The human oral microbiome (HOM) is the second largest microbial community after the gut
and can impact the onset and progression of several localized and systemic diseases …

Cascade of immune mechanism and consequences of inflammatory disorders

KB Megha, X Joseph, V Akhil, PV Mohanan - Phytomedicine, 2021 - Elsevier
Inflammatory responses arise as an outcome of tissues or organs exposure towards harmful
stimuli like injury, toxic chemicals or pathogenic microorganism. It is a complex cascade of …

Heart-rate-variability (HRV), predicts outcomes in COVID-19

MBA Mol, MTA Strous, FHM van Osch, FJ Vogelaar… - PloS one, 2021 - journals.plos.org
Background Patients with COVID-19 present with a variety of clinical manifestations, ranging
from mild or asymptomatic disease to severe illness and death. Whilst previous studies have …

[HTML][HTML] Profiling of oral microbiota and cytokines in COVID-19 patients

V Iebba, N Zanotta, G Campisciano, V Zerbato… - Frontiers in …, 2021 - frontiersin.org
The presence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been
recently demonstrated in the sputum or saliva, suggesting how the shedding of viral RNA …

[HTML][HTML] Identification of small molecule inhibitors of the deubiquitinating activity of the SARS-CoV-2 papain-like protease: in silico molecular docking studies and in …

E Pitsillou, J Liang, K Ververis, KW Lim, A Hung… - Frontiers in …, 2020 - frontiersin.org
COVID-19 is an ongoing pandemic caused by the SARS-CoV-2 virus with important political,
socio-economic, and public health consequences. Inhibiting replication represents an …

Immune-checkpoint inhibitors from cancer to COVID‑19: A promising avenue for the treatment of patients with COVID‑19

S Vivarelli, L Falzone, F Torino… - International …, 2021 - spandidos-publications.com
The severe acute respiratory syndrome associated coronavirus‑2 (SARS‑CoV‑2) poses a
threat to human life worldwide. Since early March, 2020, coronavirus disease 2019 (COVID …

Emerging electrochemical biosensing trends for rapid diagnosis of COVID-19 biomarkers as point-of-care platforms: A critical review

S Madhurantakam, S Muthukumar, S Prasad - ACS omega, 2022 - ACS Publications
Rapid diagnosis is a critical aspect associated with controlling the spread of COVID-19.
Electrochemical sensor platforms are ideally suited for rapid and highly sensitive detection …